Back

MATISSE

Official Title

A PHASE 3, RANDOMIZED, DOUBLE-BLINDED, PLACEBOCONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A RESPIRATORY SYNCYTIAL VIRUS (RSV) PREFUSION F SUBUNIT VACCINE IN INFANTS BORN TO WOMEN VACCINATED DURING PREGNANCY

Study Details

The purpose of the study is to evaluate the safety and efficacy of the RSV vaccine in infants born to women vaccinated during pregnancy.

Principal Investigator

Dr. Carol Kao

IRB Number

202008131

Eligibility

1. Participants must be 18 to 49 years of age and female
2. Participants must be pregnant and between 24 and 36 weeks gestation
3. Participants must not be pregnant with more than one baby (multiples)

Volunteer Information

For more information about this study, contact Volunteer for Health at:

Back